home / United States / Emergent BioSolutions

Emergent BioSolutions Market Cap

$0.59 B

+32.51 M

NYSE:EBS · January 22, 2025

Share price

$10.82

Enterprise Value

$1.08 B

Change (1-Year)

401.5%

Global Rank

#5920

Country Rank

#2256

Regions

USA

Market cap

As of January 22, 2025, Emergent BioSolutions (EBS) has a market cap of $0.59 billion USD. According to our data, Emergent BioSolutions is ranked No.5920 in global market value.

Sector Rank:

Biotech #332 Pharmaceuticals #304

EBS Market Capitalization Growth

30D Growth:

19.0%

1 Years Growth:

401.5%

3 Years Growth:

-78.6%

5 Years Growth:

-83.0%

10 Years Growth:

-65.2%

15 Years Growth:

-29.1%

20 Years Growth:

-15.6%

Total Growth:

-15%

Emergent BioSolutions Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Emergent BioSolutions Market Cap CAGR Chart

Emergent BioSolutions Market Cap History 2006 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$0.59 B	13.18%
Dec 31, 2024	$0.52 B	298.33%
Dec 29, 2023	$0.13 B	-79.68%
Dec 30, 2022	$0.64 B	-72.83%
Dec 31, 2021	$2.36 B	-51.48%
Dec 31, 2020	$4.85 B	66.08%
Dec 31, 2019	$2.92 B	-8.99%
Dec 31, 2018	$3.21 B	27.57%
Dec 29, 2017	$2.52 B	41.50%
Dec 30, 2016	$1.78 B	-17.92%
Dec 31, 2015	$2.17 B	46.93%
Dec 31, 2014	$1.48 B	18.44%
Dec 31, 2013	$1.25 B	43.33%
Dec 31, 2012	$0.87 B	-4.75%
Dec 30, 2011	$0.91 B	-28.22%
Dec 31, 2010	$1.27 B	72.63%
Dec 31, 2009	$0.74 B	-47.95%
Dec 31, 2008	$1.41 B	416.01%
Dec 31, 2007	$0.27 B	-54.66%
Dec 29, 2006	$0.60 B	100%

Similar Companies to Emergent BioSolutions

Name	Market Cap	Market cap difference	Regions
Pfizer PFE	$147.43 B	0.004 M	USA
Johnson & Johnson JNJ	$349.71 B	-0.006 M	USA
Moderna MRNA	$14.82 B	-0.000 M	USA
AstraZeneca AZN	$211.49 B	0.007 M	UK
GlaxoSmithKline GSK	$68.21 B	-0.002 M	UK
Sanofi SNY	$129.14 B	0.001 M	France
Merck MRK	$242.01 B	0.005 M	USA
Novavax NVAX	$1.41 B	-0.000 M	USA
BioNTech BNTX	$27.61 B	0.000 M	Germany
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA
Gilead Sciences GILD	$115.95 B	0.002 M	USA
AbbVie ABBV	$298.91 B	0.013 M	USA
Amgen AMGN	$146.98 B	0.004 M	USA
Eli Lilly LLY	$677.80 B	-0.006 M	USA

About Emergent BioSolutions Inc.

Name

Emergent BioSolutions Inc.

Website

https://www.emergentbiosolutions.com

Headquarters

Gaithersburg,MD

symbol

EBS

CURRENCY

USD

country

United States

fullTimeEmployees

1600

exchange

NYQ

firstTradeDateEpochUtc

2006/11/15

EBS Market Cap Formula

Market Cap	=	EBS Stock Price	*	EBS Shares Outstanding
	=	$10.82	*	54.18 M
	=	$0.59 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe